Choosing a Contract Research Organization is one of the most consequential decisions an emerging biotech leader will make. The right partner accelerates your timeline and de-risks your asset; the wrong one can lead to costly delays and operational chaos.
Too often, the due diligence process focuses on surface-level questions about cost and headcount. To find a true strategic partner, you need to go deeper. You need to probe their core methodologies, their approach to quality, and their ability to solve complex problems in real-time.
To help you navigate this critical decision, we’ve compiled the six essential questions you should ask any potential oncology CRO. These questions are designed to move beyond the sales pitch and reveal a partner’s true strategic and operational capabilities.
Question 1
How will you design a single global program to navigate divergent FDA/EMA feedback?
Why it matters
This tests for integrated regulatory strategy, not just operational task-taking.
Question 2
How does your quality system proactively implement the principles of ICH E6(R3)?
Why it matters
This tests for a modern, risk-based approach, not outdated, reactive monitoring.
Question 3
How do you use predictive analytics and real-time data to select and manage sites?
Why it matters
This tests for a data-driven methodology, not just subjective feasibility.
Question 4
What is your specific, streamlined methodology for accelerating site startup?
Why it matters
This tests for a proven, repeatable process, not an ad-hoc approach.
Question 5
Describe a time a trial went off-track. What was your recovery plan and how did you communicate with the sponsor?
Why it matters
This tests for transparency, agility, and true partnership in a crisis.
Question 6
How do you identify and mitigate AI-related risks in clinical trials while ensuring compliance across global regulatory frameworks?
Why it matters
This tests for proactive AI risk management, data security, and multi-region regulatory alignment, not just traditional compliance oversight.
A partner’s ability to answer these questions with confidence and evidence is the best indicator of their ability to guide your innovative therapy to success. At Accelsiors, our entire model is built to provide these answers.
If you’re ready to partner with a CRO that has the right answers, let’s connect.